Log in
Regional Drug & Therapeutics Centre - RDTC logo
  • Home
  • About
  • Staff
  • Contact Us
  • Manage Account
  • Login
Home » Prescribing Support » Evaluation report

Evaluation report

Document Type Published
Insulin aspart Sanofi (Trurapi): Biosimilar Insulin Aspart Evaluation report March 2022
Omalizumab and dupilumab for chronic rhinosinusitis with nasal polyps Evaluation report September 2021
Solriamfetol for obstructive sleep apnoea Evaluation report June 2021
Solriamfetol for narcolepsy Evaluation report May 2021
Doxylamine and pyridoxine (Xonvea) for the treatment of nausea and vomiting of pregnancy Evaluation report February 2019
ActiPatch for the management of localised musculoskeletal pain Evaluation report January 2019

Follow RDTC on Twitter

Our opening hours

Our opening hours are Monday to Friday: 9am – 5pm

  • Cookie Information
  • Site Disclaimer
  • Terms and Conditions
  • Copyright Notice
  • Privacy Statement